On the rarer but more serious front, GLP-1 RAs have been associated with increased risks of thyroid cancer and pancreatitis.7 9 Though uncommon, it's critical that you divulge any thyroid issues, pancreatic concerns, or family history of cancer to your doctor
First, Alzheimers disease and other dementias are strongly linked to metabolic dysfunctionespecially insulin resistance in the brain, sometimes labeled type 3 diabetes. Second, a class of diabetes and weight-management medicines called GLP-1 receptor agonists (GLP-1 RAs) shows early but increasingly consistent signals that they may lower dementia risk in people with type 2 diabetes, and possibly slow specific biological changes of Alzheimers in small clinical trials
These impacts are especially noticeable in the first four to eight weeks of a patients GLP-1 weight loss journey, leading to issues like constipation, nausea, bloating, vomiting, and other gastrointestinal discomforts
Double your dose
In parallel, the viability was scored using resazurin, and the results adjusted for the percentage of viable cells relative to the GSH content of WT cells
Arch.Gerontol.Geriatr